| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Nazartinib |
|---|
| Description | Nazartinib is a potent, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. It covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. MW: 495.02. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide; EGF816; NSV816 |
|---|
| Gene, Accession, CAS # | CAS: 1508250-71-2 |
|---|
| Catalog # | B2288-5 |
|---|
| Price | |
|---|
| Order / More Info | Nazartinib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|